Your browser doesn't support javascript.
loading
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial.
Sher, Lawrence D; Wechsler, Michael E; Rabe, Klaus F; Maspero, Jorge F; Daizadeh, Nadia; Mao, Xuezhou; Ortiz, Benjamin; Mannent, Leda P; Laws, Elizabeth; Ruddy, Marcella; Pandit-Abid, Nami; Jacob-Nara, Juby A; Gall, Rebecca; Rowe, Paul J; Deniz, Yamo; Lederer, David J; Hardin, Megan.
  • Sher LD; Peninsula Research Associates, Rolling Hills Estates, CA. Electronic address: lawrence.sher@peninsularesearch.com.
  • Wechsler ME; National Jewish Health, The NJH Cohen Family Asthma Institute, Denver, CO.
  • Rabe KF; LungenClinic Grosshansdorf and Christian Albrechts University of Kiel, members of the German Center for Lung Research (DZL), Kiel, Germany.
  • Maspero JF; Fundación CIDEA, Buenos Aires, Argentina.
  • Daizadeh N; Sanofi, Cambridge, MA.
  • Mao X; Sanofi, Bridgewater, NJ.
  • Ortiz B; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Mannent LP; Sanofi, Chilly-Mazarin, France.
  • Laws E; Sanofi, Bridgewater, NJ.
  • Ruddy M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Pandit-Abid N; Sanofi, Bridgewater, NJ.
  • Jacob-Nara JA; Sanofi, Bridgewater, NJ.
  • Gall R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Rowe PJ; Sanofi, Bridgewater, NJ.
  • Deniz Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Lederer DJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Hardin M; Sanofi, Cambridge, MA.
Chest ; 162(1): 46-55, 2022 07.
Article en En | MEDLINE | ID: mdl-35217003

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article